Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01406769 · ClinicalTrials.gov registry record · Phase 2
Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy
A Phase 2 study, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT01406769 is a Phase 2 study that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 120 participants.
The verdict
NCT01406769, a Phase 2 study, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
This phase II trial studies bioimpedance spectroscopy in detecting lower-extremity lymphedema in patients with stage I, stage II, stage III, or stage IV vulvar cancer undergoing surgery and lymphadenectomy. Diagnostic procedures, such as bioimpedance spectroscopy, may help doctors to predict the onset of lower-extremity lymphedema in patients with vulvar cancer undergoing surgery.
Interventions
- PROCEDURE Therapeutic Conventional Surgery
- PROCEDURE Lymphadenectomy
- PROCEDURE Bioelectric Impedance Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2012-07-16 |
| Est. Completion | 2020-04-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01406769
The ClinicalTrials.gov registry entry for NCT01406769 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Therapeutic Conventional Surgery is the first listed.
NCT01406769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01406769 about?
NCT01406769 is a clinical study titled "Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy". This phase II trial studies bioimpedance spectroscopy in detecting lower-extremity lymphedema in patients with stage I, stage II, stage III, or stage IV vulvar cancer undergoing surgery and lymphadenectomy. Diagnostic procedures, such as bioimpedance spectroscopy, may help doctors to predict the ons...
What is the current status of trial NCT01406769?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2012-07-16. Estimated completion is 2020-04-10.
What interventions are being tested in trial NCT01406769?
The interventions under investigation include: Therapeutic Conventional Surgery (PROCEDURE), Lymphadenectomy (PROCEDURE), Bioelectric Impedance Analysis (PROCEDURE).
Who is sponsoring clinical trial NCT01406769?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.